SecBot SecBot
6-K ·Filed Apr 21, 2026

ASND

Ascendis Pharma A/S
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001193125-26-165330
Notable filing: 6-K
Actionable Insight • Neutral

Update ISIN in trading and settlement systems to DK0060615755 to ensure accurate processing of transactions. No investment thesis implications.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$240.29
T+0 close · Apr 21, 2026 · via day close
Latest settled
+8.12%
T+60 · $259.80
Vs SPY
+1.22%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 21 $240.29entry
  2. T+1 · 7mo ago −3.85%α −4.86% · $231.05
  3. T+5 · 7mo ago −7.58%α −8.66% · $222.08
  4. T+20 · 6mo ago −1.10%α −6.02% · $237.64
  5. T+60 · 4mo ago +8.12%α +1.22% · $259.80
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Ascendis Pharma A/S updated the International Securities Identification Number (ISIN) for its ordinary shares to DK0060615755 following its direct listing on Nasdaq, replacing the previously disclosed ISIN DK0060606333. The CUSIP number and ticker symbol (ASND) remain unchanged.

Key Facts

  • Updated ISIN for ordinary shares to DK0060615755 as confirmed by Denmark's National Numbering Agency
  • Previous ISIN DK0060606333 is no longer valid
  • CUSIP number (K08588103) and ticker symbol (ASND) remain unchanged
  • Update relates to administrative details following direct listing on Nasdaq

Financial Impact

No financial impact

none

Risk Factors

  • Potential for trade fails or settlement issues if outdated ISIN is used
  • Temporary confusion among investors or systems not updated with new ISIN

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001193125-26-165330
Document: 0001193125-26-165330-index-headers.html0001193125-26-165330
Document: 0001193125-26-165330-index.html0001193125-26-165330
Document: 0001193125-26-165330.txt0001193125-26-165330

Track record

41 reports on ASND

Performance horizon

14 of 19 bullish or bearish reports moved the stock their way by T+60. Best: +26.62% at T+20 after the Jun 2, 2026 report. 25 of 27 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $271.96 Now $271.73 −0.08% settles Feb 12
  2. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $275.39 Now $271.73 −1.33% settles Feb 11
  3. Nov 12, 20264d ago 6-K Bullish 6/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
  4. Nov 12, 20264d ago Press Release Neutral 5/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
  5. Nov 6, 202610d ago 6-K Bullish 6/10 Entry $259.85 Now $271.73 +4.57% settles Feb 5
  6. Nov 6, 202610d ago Press Release Bullish 6/10 Entry $256.82 Now $271.73 +5.81% settles Feb 4
  7. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $253.45 Now $271.73 +7.21% settles Feb 3
  8. Nov 2, 202614d ago Institutional Cluster Bullish 4/10 Entry $250.17 Now $271.73 +8.62% settles Feb 1
  9. Oct 26, 202621d ago 6-K Bullish 5/10 Entry $245.85 Now $271.73 +10.53% settles Jan 25
  10. Oct 16, 20264w ago 6-K Bullish 7/10 Entry $225.25 Now $271.73 +20.63% settles Jan 13
Showing 10 of 41

US Market Status

Market Closed · Opens Wed (11h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026